Fahradyan A, Howell AC, Wolfswinkel EM, Tsuha M, Sheth P, Wong AK. Updates on the management of non-melanoma skin cancer (NMSC). Healthcare (Basel). 2017;5(4):82. https://doi.org/10.3390/healthcare5040082.

Tanese K, Nakamura Y, Hirai I, Funakoshi T. Updates on the Systemic treatment of advanced non-melanoma skin cancer. Front Med (Lausanne). 2019;6:160.

Article  PubMed  Google Scholar 

Hu W, Fang L, Ni R, Zhang H, Pan G. Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer. 2022;22(1):836.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv R, Sun Q. A network meta-analysis of non-melanoma skin cancer (NMSC) treatments: efficacy and safety assessment. J Cell Biochem. 2017;118(11):3686–95.

Article  CAS  PubMed  Google Scholar 

St Claire K, Hoover A, Ashack K, Khachemoune A. Extramammary Paget disease. Dermatol Online J. 2019;25(4):13030/qt7qg8g292.

Win TS, Tsao H. Keratinocytic skin cancers-Update on the molecular biology. Cancer. 2023;129(6):836–44.

Article  PubMed  Google Scholar 

Lai M, Pampena R, Cornacchia L, Odorici G, Piccerillo A, Pellacani G, et al. Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: a systematic review of the literature. Int J Dermatol. 2022;61(5):548–57.

Article  PubMed  Google Scholar 

Hernandez LE, Mohsin N, Levin N, Dreyfuss I, Frech F, Nouri K. Basal cell carcinoma: An updated review of pathogenesis and treatment options. Dermatol Ther. 2022;35(6):e15501.

Article  CAS  PubMed  Google Scholar 

Khandelwal AR, Echanique KA, St John M, Nathan CA. Cutaneous cancer biology. Otolaryngol Clin North Am. 2021;54(2):259–69.

Article  PubMed  Google Scholar 

Malvehy J, Pellacani G. Dermoscopy, confocal microscopy and other non-invasive tools for the diagnosis of non-melanoma skin cancers and other skin conditions. Acta Derm Venereol. 2017;Suppl 218:22–30.

PubMed  Google Scholar 

Werner RN, Stockfleth E, Connolly SM, Correia O, Erdmann R, Foley P, et al. Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version. J Eur Acad Dermatol Venereol. 2015;29(11):2069–79.

Article  CAS  PubMed  Google Scholar 

Ramelyte E, Nageli MC, Hunger R, Merat R, Gaide O, Navarini AA, et al. Swiss recommendations for cutaneous basal cell carcinoma. Dermatology. 2023;239(1):122–31.

Article  PubMed  Google Scholar 

Tamas T,  Dinu C, Lenghel LM, Boțan E, Tamas A, Stoia S, et al. High-frequency ultrasound in diagnosis and treatment of non-melanoma skin cancer in the head and neck region. Diagnostics (Basel). 2023;13(5):1002. https://doi.org/10.3390/diagnostics13051002.

Backman EJ, Polesie S, Berglund S, Gillstedt M, Sjoholm A, Modin M, et al. Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial. J Eur Acad Dermatol Venereol. 2022;36(10):1758–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fournier S, Laroche A, Leblanc M, Bourgeault E, Ulrich Singbo MN, Turcotte S, et al. Prospective Clinical Trial comparing curettage and cryosurgery to curettage and electrodesiccation in the management of minimally invasive basal and squamous cell carcinomas [Formula: see text]. J Cutan Med Surg. 2020;24(6):596–600.

Article  CAS  PubMed  Google Scholar 

Srivastava P, Kumar A. An experimental study to characterise the role of multihole nozzle in adjuvant assisted cryospray. Int J Therm Sci. 2023;183:107838.

Article  CAS  Google Scholar 

Paasch U, Zidane M, Baron JM, Bund T, Cappius HJ, Drosner M, et al. S2k guideline: Laser therapy of the skin. J Dtsch Dermatol Ges. 2022;20(9):1248–67.

PubMed  Google Scholar 

Benson TA, Hibler BP, Kotliar D, Avram M. Nonablative fractional laser treatment is associated with a decreased risk of subsequent facial keratinocyte carcinoma development. Dermatol Surg. 2023;49(2):149–54.

Article  CAS  PubMed  Google Scholar 

Scurtu LG, Petrica M, Grigore M, Avram A, Popescu I, Simionescu O. A conservative combined laser cryoimmunotherapy treatment vs. surgical excision for basal cell carcinoma. J Clin Med. 2022;11(12):3439. https://doi.org/10.3390/jcm11123439.

Collins A, Savas J, Doerfler L. Nonsurgical treatments for nonmelanoma skin cancer. Dermatol Clin. 2019;37(4):435–41.

Article  CAS  PubMed  Google Scholar 

Schmults CD, Blitzblau R, Aasi SZ, Alam M, Andersen JS, Baumann BC, et al. NCCN guidelines(R) insights: squamous cell skin cancer, Version 1.2022. J Natl Compr Canc Netw. 2021;19(12):1382–94.

Article  CAS  PubMed  Google Scholar 

Muto P, Pastore F. Radiotherapy in the adjuvant and advanced setting of CSCC. Dermatol Pract Concept. 2021;11(Suppl 2):e2021168S.

Article  PubMed  PubMed Central  Google Scholar 

Locke J, Karimpour S, Young G, Lockett MA, Perez CA. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):748–55.

Article  CAS  PubMed  Google Scholar 

Ceovic R, Petkovic M, Mokos ZB, Kostovic K. Nonsurgical treatment of nonmelanoma skin cancer in the mature patient. Clin Dermatol. 2018;36(2):177–87.

Article  PubMed  Google Scholar 

De Felice F, Musio D, De Falco D, Grapulin L, Magnante AL, Caiazzo R, et al. Definitive weekly hypofractionated radiotherapy in cutaneous squamous cell carcinoma: response rates and outcomes in elderly patients unfit for surgery. Int J Dermatol. 2022;61(8):911–5.

Article  PubMed  Google Scholar 

Vaishampayan P, Curiel-Lewandrowski C, Dickinson SE. Review: PD-L1 as an emerging target in the treatment and prevention of keratinocytic skin cancer. Mol Carcinog. 2023;62(1):52–61.

Article  CAS  PubMed  Google Scholar 

Ghidini A, Santangelo D, Vaccaro G, Chillura M, Petrelli F. Cemiplimab in cutaneous squamous cell carcinomas (SCC): an overview and a clinical case. Oral Oncol. 2022;128:105847.

Article  CAS  PubMed  Google Scholar 

Hughes BGM, Munoz-Couselo E, Mortier L, Bratland A, Gutzmer R, Roshdy O, et al. Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276–1285]. Ann Oncol. 2022;33(8):853.

Zhang H, Zhong A, Chen J. Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: a systemic review and meta-analysis. Skin Res Technol. 2023;29(1):e13229.

Article  PubMed  Google Scholar 

Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Annamalai L, et al. PD-1 Blockade with pembrolizumab in advanced merkel-cell carcinoma. N Engl J Med. 2016;374(26):2542–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ansary TM, Hossain MDR, Komine M, Ohtsuki M. Immunotherapy for the treatment of squamous cell carcinoma: potential benefits and challenges. Int J Mol Sci. 2022;23(15):8530. https://doi.org/10.3390/ijms23158530.

Veron M, Chevret S, Grob JJ, Beylot-Barry M, Saiag P, Flechon A, et al. Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSe NIVOLUMAB trial. Eur J Cancer. 2022;177:103–11.

Article  CAS  PubMed  Google Scholar 

Wilken R, Criscito M, Pavlick AC, Stevenson ML, Carucci JA. Current Research in melanoma and aggressive nonmelanoma skin cancer. Facial Plast Surg. 2020;36(2):200–10.

Article  PubMed  Google Scholar 

Clingan P, Ladwa R, Brungs D, Harris DL, McGrath M, Arnold S, et al. Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma. J Immunother Cancer. 2023;11(10):e007637. https://doi.org/10.1136/jitc-2023-007637. A Phase I clinical trial, for the first time, assessed the efficacy and safety of a PD-L1-blocking antibody in metastatic cutaneous squamous cell carcinoma.

Bennardo L, Bennardo F, Giudice A, Passante M, Dastoli S, Morrone P, et al. Local Chemotherapy as an adjuvant treatment in unresectable squamous cell carcinoma: what do we know so far? Curr Oncol. 2021;28(4):2317–25.

Article  PubMed  PubMed Central  Google Scholar 

Huang JW, Kuo CL, Wang LT, Ma KS, Huang WY, Liu FC, et al. Case report: in situ vaccination by autologous CD16(+) dendritic cells and anti-PD-L 1 antibody synergized with radiotherapy to boost T cells-mediated antitumor efficacy in a psoriatic patient with cutaneous squamous cell carcinoma. Front Immunol. 2021;12:752563.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Savoia P, Cremona O, Fava P. New perspectives in the pharmacological treatment of non-melanoma skin cancer. Curr Drug Targets. 2016;17(3):353–74.

Article  CAS  PubMed  Google Scholar 

Di Nardo L, Pellegrini C, Di Stefani A, Del Regno L, Sollena P, Piccerillo A, et al. Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies. J Eur Acad Dermatol Venereol. 2020;34(5):932–41.

Article  PubMed  Google Scholar 

Picard A, Pedeutour F, Peyrade F, Saudes L, Duranton-Tanneur V, Chamorey E, et al. Association of oncogenic mutations in patients with advanced cutaneous squamous cell carcinomas treated with cetuximab. JAMA Dermatol. 2017;153(4):291–8.

Article  PubMed  Google Scholar 

Xu G, Fang J, Xu J, Shen Z, Huang C, Jiang Y. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions. Bioengineered. 2021;12(2):9930–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Nakahara T, Uchi H, Takeuchi S, Takahara M, Kido M, et al. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget’s disease. Br J Dermatol. 2009;161(2):357–63.

Article  CAS  PubMed  Google Scholar 

Gluck M, Hodak E, Davidovici B. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients. Dermatol Ther. 2022;35(8):e15649.

Article  CAS